Archives

by in
Entry Author Date Location
UW Spinoff Resolve Therapeutics Snags $5.8M for Lupus Drug 11/01/12 Seattle
Innovimmune Pursues Pharma Partners, Shuns VCs 08/07/12 New York
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Pfizer, deCode Genetics Strike Deal To Look For New Lupus Drug Targets 10/12/11 New York
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired 05/23/11 National
The New Normal for Biotech Startups 01/26/11 Seattle
Adimab Adds Genentech, Lilly, and Human Genome Sciences to Growing List of Partners 12/15/10 Boston
Resolve Therapeutics, UW Spinoff With an Eye on Lupus, Crafts Recession-Era Business Plan 11/10/10 Seattle
La Jolla Pharmaceutical Revives With $6M Financing 05/26/10 San Diego
La Jolla Pharmaceutical: Going, Going, But Not Quite Gone 02/26/10 San Diego
Lycera, a Midwestern Biotech Star, Moves Head Office to Boston, Hires Biogen Vet as CEO 01/07/10 Boston
Zymo Drug Fails Arthritis Trials 09/10/09 Seattle
ZymoGenetics Picks Up Mojo, Dendreon Looks Southeast, Cell Therapeutics Raises Dough & More Seattle-Area Life Sciences News 07/23/09 Seattle
ZymoGenetics Picks Up Some of Human Genome Sciences’ Mojo With Lupus Drug 07/21/09 Seattle
La Jolla Pharmaceutical Gets Delisting Notice 04/09/09 San Diego
Biogen Idec, Extending Life of its Top-Selling Drug, Eyes Longer-Lasting Shot for MS 03/27/09 Boston
Trubion Starts Lupus Trial 03/25/09 Seattle
Biogen Idec, Genentech’s Rituxan Fails in Pivotal Study of Lupus of Kidneys 03/11/09 Boston
Cypress Buys Lupus Test 02/24/09 San Diego
La Jolla Pharmaceutical Looks at Sale or “Winding Down” 02/20/09 San Diego
La Jolla Pharmaceutical Stock Crashes After Drug Fails In Pivotal Clinical Trial 02/12/09 San Diego
Sequenom Buys Small Diagnostic Maker 01/26/09 San Diego
La Jolla Pharma Inks BioMarin Deal 01/07/09 San Diego
VLST Snags Partnership with Novo Nordisk to Develop New Drugs for Autoimmunity 12/17/08 Seattle
ZymoGenetics Drug For Hepatitis C Kills Virus with Minimal Side Effects 11/03/08 Seattle
ZymoGenetics Drug Trial Halted Because of Infection Risk 10/27/08 Seattle
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA 09/03/08 Seattle
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010 08/05/08 Seattle
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Venture Funding Slows as VC Industry Contracts, & Top 10 Deals List
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.